In a biopsy-based study, Castera et al. demonstrated that men with ALT ≥ 30 IU/L and women with ALT ≥ 20 IU/L had a higher prevalence of nonalcoholic steatohepatitis and liver fibrosis [18]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.